Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

60.46 +1.53 (+2.60%)

Streaming Delayed Price Updated: 11:31 AM EST, Feb 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

38 39 Next >

The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗

June 05, 2022

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.

Via Benzinga

Week In Review: Vivo Raises $600 Million In First Tranche Of China PE Fund ↗

June 04, 2022

Vivo Capital held its first closing of a yuan-denominated private equity fund at $600 million, with a target of bringing the fund to $1.5 billion. Meanwhile, ProfoundBio closed a $70 million Series A+...

Via Talk Markets

6 Biotech Stocks to Buy Now Ahead of These June Catalysts ↗

June 03, 2022

These biotech stocks face some key make-or-break events in June that could have big implication for their futures.

Via InvestorPlace

3 Undervalued Dividend Growth Stocks ↗

June 01, 2022

Investors who focus on a strategy of dividend growth stocks have performed better than some broader stock market indices.

Via InvestorPlace

GlaxoSmithKline: Dividend Insights ↗

May 16, 2022

Wednesday marks the last chance for investors to receive the next dividend payout from GlaxoSmithKline (NYSE:GSK).

Via Benzinga

Recap: GlaxoSmithKline Q1 Earnings ↗

April 27, 2022

GlaxoSmithKline (NYSE:GSK) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

GSK Confirms Consumer Healthcare Unit Spin-off: What Investors Should Know ↗

June 01, 2022

Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc.

Via Benzinga

Morning Brief: Top Financial Stories Dominating on Wednesday, June 1 ↗

June 01, 2022

Reuters Redbird Capital Buys Italian Football Club AC Milan

Via Benzinga

Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off ↗

June 01, 2022

Via Benzinga

3 Biotech Stocks to Buy Before They Boom ↗

June 01, 2022

It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.

Via InvestorPlace

Unilever Jumps After Nelson Peltz Joins Board ↗

May 31, 2022

Unilever plc (NYSE: UL) shares traded higher by 8% on Tuesday after the company announced activist investor Nelson Peltz is joining the company's board of directors.

Via Benzinga

GlaxoSmithKline Announces $3.3 Billion Buyout To Square Off With Pfizer, Merck ↗

May 31, 2022

The deal could vastly expand GlaxoSmithKline's vaccine offerings.

Via Investor's Business Daily

Morning Brief: Top Financial Stories Dominating on Tuesday, May 31 ↗

May 31, 2022

CNBC Opportunities In Crypto Crash? Top Crypto Firms Hunt For Takeovers

Via Benzinga

GSK To Scoop Clinical Stage US Biotech Affinivax For $3.3B To Shore Up Vaccine Business ↗

May 31, 2022

Via Benzinga

Unilever To Add This Activist Investor To Board - What's The Catch? ↗

May 31, 2022

Via Benzinga

Dow Up Nearly 300 Points, Eyeing Seventh-Straight Daily Win ↗

May 27, 2022

An upbeat core personal consumption expenditures price index for April is boosting investor sentiment at midday after it showed slowing inflation.

Via Talk Markets

GSK Turnaround Story ↗

May 18, 2022

GSK is already gearing up for what it hopes will be a bright future. On April 13, GlaxoSmithKline announced a $1.9 billion deal to purchase a U.S. biotech company, Sierra Oncology.

Via Talk Markets

Large Cap Biopharmaceuticals: Provide Growth, Value And Yield ↗

May 16, 2022

Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing.

Via Talk Markets

HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty ↗

May 12, 2022

Via Benzinga

Why Roche's Flop In Lung Cancer Hammered Arcus, Iteos And Others ↗

May 11, 2022

Roche isn't the only company working on an anti-TIGIT molecule.

Via Investor's Business Daily

Dividend Income Update April 2022 ↗

May 10, 2022

With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated.

Via Talk Markets

GlaxoSmithKline Clocks 32% Topline Growth Buoyed By COVID-19 Therapy, Shingrix Vaccine ↗

April 27, 2022

Via Benzinga

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗

April 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

GlaxoSmithKline's Earnings Outlook ↗

April 26, 2022

GlaxoSmithKline (NYSE:GSK) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ ↗

April 22, 2022

Via Benzinga

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data ↗

April 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance ↗

April 21, 2022

Via Benzinga

4 Undervalued Biotech Stocks to Add to Your Buy List ↗

April 20, 2022

These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.

Via InvestorPlace

As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ ↗

April 18, 2022

In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a...

Via Benzinga

The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More ↗

April 17, 2022

Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting...

Via Benzinga

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

38 39 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.